THE BRAINCOOL™ SYSTEM FOR STROKE AND CARDIAC ARREST
BrainCool AB is a Swedish medical device company listed since May 2014 on the Swedish Stock Exchange.
The vision is to create “The Medical Cooling Company” with a clear focus on bringing products with highly innovative, medical cooling technologies with an initial focus on brain cooling for stroke and cardiac arrest and the prevention of oral mucositis. These products will create a de facto standard in their field.
Therapeutic hypothermia, or cooling, lowers a patient’s body temperature to help reduce the risk of injury to the brain following a period of insufficient blood flow due to an ischemic event, such as cardiac arrest, stroke or traumatic brain injury. Cooling begins after the patient is admitted to the hospital.
Two landmark human studies published simultaneously in 2002 by the New England Journal of Medicine demonstrated the positive effects of mild hypothermia applied following cardiac arrest.
•A brain hypothermia device for the stroke market – The BrainCool™System
•A brain hypothermia device for the cardiac arrest market – The BrainCool™System ( the same product with a different configuration )
The system includes a state of the art cooling unit with advanced monitoring and shiver control settings along with the single patient use accessories – BrainCool Pads